Concepedia

Christopher Pleyer

CP

Statistics

Publications

8

Citations

450

H-Index

8

Active since

2014

Affiliations

National Institutes of Health(Current)

National Heart Lung and Blood Institute

Mayo Clinic in Arizona

National Institute of Allergy and Infectious Diseases

Cleveland Clinic

Christopher Pleyer is an author at National Institutes of Health specializing in medicine, immunology, and oncology.

ORCID

Publications per year

2014–2022

8

Publications

8

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Christopher Pleyer, Mir A. Ali, Jeffrey I. Cohen et al. · Blood · 2020 · 140 citations · Full text

, , +16

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

Clare Sun, Pia Nierman, Ellen K. Kendall et al. · Blood · 2020 · 106 citations · Full text

, , +15

Overdiagnosis of gastro‐esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community

Christopher Pleyer, H Bittner, G. Richard Locke et al. · Neurogastroenterology & Motility · 2014 · 57 citations

, , +12

Lysozyme amyloidosis – a case report and review of the literature

Christopher Pleyer, Jan Flesche, Fahad Saeed · Clinical Nephrology - Case Studies · 2015 · 37 citations · Full text

, , +14

Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine

Remco J. Molenaar, Christopher Pleyer, Tomas Radivoyevitch et al. · Leukemia · 2017 · 36 citations · Full text

, , +16

1–5 of 8